Startseite Naturwissenschaften Crystal structure of 5,17-bis-cyano-25,26,27,28-tetrapropyloxy-calix[4]arene, C42H46N2O4
Artikel Open Access

Crystal structure of 5,17-bis-cyano-25,26,27,28-tetrapropyloxy-calix[4]arene, C42H46N2O4

  • Fethi Elaieb , David Sémeril EMAIL logo , Dominique Matt EMAIL logo und Ahmed Hedhli
Veröffentlicht/Copyright: 6. Mai 2016

Abstract

C42H46N2O4, orthorhombic, Pcca (No. 54), a = 14.9100(5), b = 17.2508(6), c = 16.0857(6) Å, V = 4137.4(3) Å3, Z = 4, Rgt(F) = 0.0710, wRref(F2) = 0.2308, T = 173 K.

CCDC no.:: 1474549

Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless, Prism, size 0.50×0.45×0.40 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.66 cm−1
Diffractometer, scan mode:Bruker Apex II, φ and ω
2θmax, completeness:58.078°, >99 %
N(hkl)measured, N(hkl)unique, Rint:35713, 5504, 0.0304
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 3893
N(param)refined:233
Programs:CrysAlis [6], SIR−97 [7], SHELX [8], PLATON [9]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C10.13609(11)0.81583(11)0.43074(11)0.0398(4)
C20.19732(13)0.86541(12)0.46900(13)0.0496(5)
H20.18640.88260.52420.059*
C30.27366(13)0.88986(13)0.42795(15)0.0542(5)
H30.31590.92200.45560.065*
C40.28852(12)0.86742(12)0.34604(14)0.0488(5)
H40.34020.88560.31750.059*
C50.22802(11)0.81817(11)0.30498(12)0.0399(4)
C60.15468(11)0.79039(10)0.35039(11)0.0371(4)
C70.23495(11)0.80088(12)0.21339(12)0.0425(4)
H7A0.22980.74430.20410.051*
H7B0.29410.81810.19230.051*
C8−0.16047(10)0.84285(10)0.33337(10)0.0358(4)
C9−0.14853(11)0.92183(10)0.32185(11)0.0379(4)
H9−0.18860.94970.28710.046*
C10−0.07803(11)0.96065(10)0.36095(11)0.0372(4)
C11−0.01741(11)0.91992(10)0.40990(11)0.0377(4)
H110.03120.94660.43520.045*
C12−0.02712(11)0.84092(10)0.42214(10)0.0361(4)
C13−0.10032(11)0.80318(10)0.38558(10)0.0348(4)
C140.04579(12)0.79722(11)0.46952(11)0.0418(4)
H14A0.04550.81300.52870.050*
H14B0.03440.74070.46670.050*
C15a0.0989(4)0.6618(3)0.3350(3)0.0738(11)
H15Aa0.12130.65900.39280.089*
H15Ba0.03700.64110.33500.089*
C16a0.1531(4)0.6125(3)0.2848(4)0.0957(14)
H16Aa0.21710.62440.29480.115*
H16Ba0.14020.62270.22540.115*
C17a0.1354(6)0.5260(3)0.3039(5)0.132(3)
H17Aa0.14100.51700.36380.198*
H17Ba0.17930.49400.27420.198*
H17Ca0.07480.51210.28570.198*
C15Bb0.1260(10)0.6666(7)0.3046(8)0.0738(11)
H15Cb0.19170.66610.31320.089*
H15Db0.11390.64720.24780.089*
C16Bb0.0817(9)0.6118(6)0.3681(9)0.0957(14)
H16Cb0.10600.62420.42390.115*
H16Db0.01670.62320.36930.115*
C17Bb0.0933(15)0.5275(8)0.3537(14)0.132(3)
H17Db0.15680.51610.34360.198*
H17Eb0.05790.51170.30520.198*
H17Fb0.07280.49880.40280.198*
C18−0.1640(2)0.70562(14)0.46915(18)0.0706(8)
H18A−0.22370.73060.46500.085*
H18B−0.13410.72520.51990.085*
C19−0.1749(3)0.62031(18)0.4749(3)0.1046(13)
H19Aa−0.20810.60930.52690.126*
H19Ba−0.21410.60410.42840.126*
H19Cb−0.11760.60100.49800.126*
H19Db−0.22040.61210.51890.126*
C20a−0.0958(4)0.5697(3)0.4738(4)0.1092(17)
H20Aa−0.05870.58210.42530.164*
H20Ba−0.11500.51550.47070.164*
H20Ca−0.06080.57780.52460.164*
C20Bb−0.1957(11)0.5718(8)0.4163(10)0.1092(17)
H20Db−0.25170.58830.38960.164*
H20Eb−0.20370.51990.44010.164*
H20Fb−0.14760.57050.37480.164*
C21−0.06541(12)1.04223(11)0.34768(11)0.0422(4)
O10.09512(8)0.74173(8)0.31115(9)0.0442(3)
O2−0.11140(8)0.72482(7)0.39753(8)0.0419(3)
N1−0.05521(13)1.10738(11)0.33756(12)0.0550(5)

aOccupancy: 0.823(4); bOccupancy: 0.177(4).

Source of material

A suspension of 5,17-dibromo-25,26,27,28-tetrapropyloxycalix[4]arene (0.188 g, 0.25 mmol), [Pd(OAc)2] (0.006 g, 0.0025 mmol), 1,3-bis(diphenylphosphino)propane (0.021 g, 0.005 mmol) and Zn(CN)2 (0.117 g, 1.00 mmol) in DMF (2.5 mL) was heated at 140°C under argon. After 72 h, the reaction mixture was cooled to room temperature and passed through a plot of silica gel. The solvent was evaporated and the solid residue was purified by column chromatography (CH2Cl2/petroleum ether, 1:1 v/v) to afford the title compound as a white solid, yield 0.131 g, 82 %. 1H NMR (CDCl3, 400 MHz): δ = 6.83 (s, 4H, arom. CH), 6.75 (s, 6H, arom. CH), 4.43 and 3.17 (AB spin system, 8H, ArCH2Ar, 2J = 13.6 Hz), 3.87 (t, 4H, OCH2, 3J = 8.0 Hz), 3.85 (t, 4H, OCH2, 3J = 7.2 Hz), 1.95–1.85 (m, 8H, CH2CH3), 1.03 (t, 6H, CH2CH3, 3J = 7.4 Hz), 0.95 (t, 3H, CH2CH3, 3J = 7.4 Hz); 13C NMR (CDCl3, 125 MHz): δ = 160.01 (s, arom Cq—O), 156.59 (s, arom Cq—O), 136.27–105.71 (arom. Cs), 119.06 (s, CN), 77.35 (s, OCH2), 76.92 (s, OCH2), 30.79 (s, ArCH2Ar), 23.41 (CH2CH3), 23.18 (CH2CH3), 10.47 (CH2CH3), 10.18 (CH2CH3) ppm; IR: ν = 2223 cm−1 (CN); elemental analysis calcd (%) for C42H46O4N2 (Mr = 642.83): C 78.47, H 7.21, N 4.36; found (%): C 78.52, H 7.18, N 4.41.

Experimental details

The structure was solved by direct methods using the program SIR-97 [7] and refined with SHELXL-2014/6 [8]. The Figure was drawn with CrysAlis software [6]. Carbon-bound H atoms were placed in calculated positions (C—H 0.95 Å for aromatic and C—H 0.99 Å for methylene groups) and were included in the refinement in the riding model approximation, with Uiso(H) set to 1.2Ueq(C). The H atoms of the methyl groups were allowed to rotate with a fixed angle around the C—C bond to best fit the experimental electron density (HFIX 137 in the SHELX program suite [9]), with Uiso(H) set to 1.5Ueq(C). The dataset was managed using the program SQUEEZE [9]. The residual electron density was assigned to half a molecule of the dichloromethane solvent [179/8 = 22 eper asymmetric unit; half a molecule of CH2Cl2 would give 21e]. The propyl chains are disordered over two positions.

Discussion

Crystals of the title compound suitable for X-ray diffraction formed readily upon diffusion of methanol into a dichloromethane solution of the dicyano calixarene. In the solid state, the calix[4]arene cavity adopts a typical pinched cone conformation [13], with interplanar angles between opposite phenoxy rings of 21.2° and 76.2°, respectively. The separations between the aromatic para-carbon atoms of opposite phenolic rings are 4.26 and 9.97 Å, respectively. The 1H NMR spectrum of the title compound is in keeping with a C2v-symmetrical molecule. The diastereotopic ArCH2Ar protons appear as a single AB pattern with a large AB separation (> 1 ppm), this being consistent with a calixarene unit in the cone conformation. The CN bond lengths (N(1)—C(21) 1.146(3) Å) lie in the range found for other cyano-substituted calixarenes [4, 5].

References

1. Frediani, M.; Sémeril, D.; Mariotti, A.; Rosi, L.; Frediani, P.; Rosi, L.; Matt, D.; Toupet, L.: Ring opening polymerization of lactide under solvent-free conditions catalyzed by a chlorotitanium calix[4]arene complex. Macromol. Rapid Commun. 29 (2008) 1554–1560.10.1002/marc.200800383Suche in Google Scholar

2. Monnereau, L.; Sémeril, D.; Matt, D.; Toupet, L.; Mota, A. J.: Efficient, nickel-catalysed Kumada-Tamao-Corriu cross-coupling with a calix[4]arene-diphosphine ligand. Adv. Synth. Catal. 351 (2009) 1383–1389.10.1002/adsc.200800759Suche in Google Scholar

3. Monnereau, L.; Sémeril, D.; Matt, D.; Toupet, L.: Micellar effects in olefin hydroformylation catalysed by neutral, calix[4]arene-diphosphite rhodium complexes. Adv. Synth. Catal. 351 (2009) 1629–1636.10.1002/adsc.200900074Suche in Google Scholar

4. Mislin, G.; Graf, E.; Hosseini, M. W.; De Cian, A.; Kyritsakas, N.; Fischer, J.: Synthesis and structural analysis of an infinite linear coordination network formed by the self-assembly of tetracyanocalix[4]arene ligands and silver cations. Chem Commun. (1998) 2545–2546.10.1039/a807434hSuche in Google Scholar

5. Budka, J.; Eigner, V.; Holakovsky, Kovarícek, T.; Louzilová, T.: 25,26,27,28-Tetrapropoxycalix[4]arene-5,17-dicarbonitrile. Acta Crystallogr. E66 (2010) o419–o420.10.1107/S1600536810002242Suche in Google Scholar PubMed PubMed Central

6. Agilent (2014), CrysAlisPro Version 1.171.37.35, Agilent Technologies UK Ldt, Yarnton, England.Suche in Google Scholar

7. Altomare, A.; Burla, M. C.; Camalli, M.; Cascarano, G. L.; Giacovazzo, C.; Guagliardi, A.; Moliterni, A. G. G.; Polidori, G.; Spagna, R.: SIR97: a new tool for crystal structure determination and refinement. J. Appl. Cryst. 32 (1999) 115–119.10.1107/S0021889898007717Suche in Google Scholar

8. Sheldrick, G. M.: Crystal structure refinement with SHELX. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Suche in Google Scholar PubMed PubMed Central

9. Spek, A.: Single-crystal structure validation with the program PLATON. J. Appl. Cryst. 36 (2003) 7–13.10.1107/S0021889802022112Suche in Google Scholar

Received: 2016-2-19
Accepted: 2016-4-18
Published Online: 2016-5-6
Published in Print: 2016-9-1

©2016 Fethi Elaieb et al., published by De Gruyter.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Artikel in diesem Heft

  1. Frontmatter
  2. Crystal structure of poly[aqua(μ2-2,5-bis(4-pyridyl)-1,3,4-oxadiazole-κ2N,N)(μ2-1,3-phenylenediacetato-κ3O,O′:O′′)cobalt(II)], C22H18CoN4O6
  3. Crystal structure of 2-amino-7,7-dimethyl-5-oxo-4-(3-phenoxy-phenyl)-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
  4. Crystal structure of (E)-4,4′-(diazene-1,2-diyl)bis(1-nitro-1H-1,2,4-triazol-5(4H)-one)—acetonitrile (1:1), C6H5N11O6
  5. Crystal structure of potassium (E)-5-oxo-4-((5-oxo-1H-1,2,4-triazol-4(5H)-yl)diazenyl)-4,5-dihydro-1,2,4-triazol-1-ide – (E)-4,4-diazene-1,2-diylbis(2,4-dihydro-3H-1,2,4-triazol-3-one) – methanol (1/1/1), C9H11N16KO5
  6. Crystal structure of (N,N′-bis(2-(((2,6-diisopropylphenyl)imino)methyl)phenyl)benzene-1,2-diamido-κ4O,O′,O′′,O′′′)oxidovanadium(IV), C44H48N4OV
  7. Crystal structure of 5,5-bis(4-iodophenyl)-5H-cyclopenta[2,1-b:3,4-b′]dipyridine, C23H14I2N2
  8. Crystal structure of aquadichloridobis(1-((2-methyl-1H-imidazol-1-yl)methyl)-1H-benotriazole-κN)mercury(II), C22H24Cl2HgN10O
  9. Crystal structure of 2-[4-(1H-imidazol-1-yl)phenyl]-1H-benzimidazol-3-ium [2-(carboxymethyl)phenyl]acetate monohydrate, C26H24N4O5
  10. Crystal structure of 4,4′-bipiperidinium dichloride 0.12 hydrate, C10H22N2Cl2 · 0.12 H2O
  11. Crystal structure of catena-poly[tetraaqua(μ2-4,4′(E)-ethene-1,2-diyldipyridine-κ2N:N′)nickel(II)] bis(6-methyl-2-oxo-1,2-dihydro-pyridine-4-carboxylate) pentahydrate, C26H42N4O15Ni
  12. Crystal structure of ethyl-5-amino-1-(2,4-dinitrophenyl)-1H-pyrazole-4-carboxylate, C12H11N5O6
  13. Crystal structure of dicarbonyl(pyridin-2-olate-1-oxido-κ2O,O′)rhodium(I), C7H4NO4Rh
  14. Crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)thiourea, C17H21ClN2S
  15. Crystal structure of 2-((2-chloropyridin-3-ylamino)methylene)malononitrile, C9H5ClN4
  16. Crystal structure of tetraaquabis(μ2-4-chlorobenzoato-κ2O:O,O′)bis(4-chlorobenzoato-κO)bis(1,10-phenanthroline-κ2N,N′)distrontium(II), C52H40Cl4N4O12Sr2
  17. Crystal structure of 3-hydroxy-3-phenyl-1,3-dihydro-2H-indol-2-one, C14H11NO2
  18. Crystal structures of bis(1,10-phenanthrolin-1-ium) aquapentakis(nitrato-κ2O,O′)neodym(III) monohydrate, C24H22N9NdO17
  19. Crystal structure of 2-ethyl-1-tert-butyl 3-oxo-2-[phenyl(tert-butoxycarbonylamino)methyl]-1,2-pyrrolidinedicarboxylate, C24H34N2O7
  20. Crystal structure of poly[diaquabis(μ4-benzene-1,3,5-tricarboxylato-κO1O2O3O4O5O6)-bis(μ2-4,4′-benzene-1,3-diylbis(4H-1,2,4-triazole-κ2N:N′)tricadmium(II)] tetrahydrate, C38H34Cd3N12O18
  21. Crystal structure of trans-dichlorido[1,3-bis(9-methyl-9H-fluoren-9-yl) benzimidazol-2-ylidene](pyridine)palladium(II) – a compound with anagostic CH–Pd interactions, C40H31Cl2N3Pd
  22. Crystal structure of catena-poly[(μ3-5-(4-(tetrazol-1-id-5-yl)phenoxy)benzene-1,3-dicarboxyato-κ3O:O′:N)(4-(3-(pyridin-4-yl)propyl)pyridinium-κN)zinc(II)], C28H22ZnN6O5
  23. Crystal structure of 3,6-di-2-pyridinyl-4-pyridazine carbonitrile, C15H9N5
  24. Crystal structure of 5,5,9,13-tetramethyltetracyclo[10·2·1·01,10·04,9]pentadecane-3,7,14-triol, C20H34O4
  25. Crystal structure of 2-amino-7-methyl-5-oxo-4-phenyl-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile, C16H12N2O3
  26. Crystal structure of the poly[(1,10-phenanthroline-κ2N,N′)(μ3-carboxylatophenoxyacetato-κ4O,O′:O′′;O′′′)lead(II)] monohydrate, C21H16N2O6Pb
  27. Crystal structure of the poly[(μ4-biphenyl-4,4′-dicarboxylato-κ4O:O′:O′′:O′′′) bis(μ3-8-(11-(oxysulfonyl)-4-silbenyl)-2-(oxysulfonyl)stilbene-κ4O:O′:O′′,O′′′) bis(1,10-phenanthroline-k2N,N′) dipraseodymium(III)], C94H64N4O16Pr2S4
  28. Crystal structure of 3-iodo-5-methoxy-7-(methoxymethoxy)-4-(3-methoxyphenoxy)-2H-chromen-2-one, C19H17IO7
  29. Crystal structure of poly[(5-carboxy-2,6-dimethylpyridinium-3-carboxylato-κO)tris(μ2-2,6-dimethylpyridinium-3,5-dicarboxylato-κ3O,O′:O′′)erbium(III)], C36H33ErN4O16
  30. This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3S
  31. Crystal structure of poly[(μ2-2,2′-benzene-1,2-diyldiacetato-κ2O:O′), (μ2-1-(4-(1H-imidazol-1-yl)benzyl)-1H-1,2,4-triazole-κ2N:N′)zinc(II)], C22H19N5O4Zn
  32. Crystal structure of tetraaqua(μ2-3-(3,5-dicarboxyphenoxy)benzene-1,2-dicarboxylato-κ2O:O′)manganese(II) dihydrate, C16H20O15Mn
  33. Crystal structure of 4,4′-sulfonyldipyridine, C10H8N2O2S
  34. Crystal structure of 4-[(E)-(2-chloro-6-fluorobenzylidene)amino]-1,2-dihydro-2,3-dimethyl-1-phenylpyrazol-5-one, C18H15ClFN3O
  35. Crystal structure of carbonyl(2-oxopyridin-1(2H)-olato-κ2O, O′)(triphenylphosphine-κP)rhodium(I), C24H19NO3PRh
  36. Crystal structure of diaquabis(2-(3-bromophenyl)-5-carboxy-1H-imidazol-4-carboxylato-κ2O,N) cobalt(II) trihydrate, C22H22Br2CoN4O13
  37. Crystal structure of 4-(pyridin-4-ylmethylsulfonyl)pyridine, C11H10N2O2S
  38. Crystal structure of poly[(μ4-1-methyl-1H-tetrazole-5-thiolato-κ3S:S:N:N′)copper(I)], C2H3CuN4S
  39. Crystal structure of poly[diaquabis(μ2-4,4′-sulfinyldipyridine-κ2N,N′)zinc(II)] diperchlorate dihydrate, C20H24N4O14S2Cl2Zn
  40. Crystal structure of (1-((1-benzylpyrrolidin-2-yl-κN)methyl)-3-isopropyl-1H-imidazol-2(3H)-ylidene–κC)dibromidopalladium(II), C18H25Br2N3Pd
  41. Crystal structure of pentacalcium tetranitridovanadate(V) mononitride based on a powder diffraction study, Ca5[VN4]N
  42. Crystal structure of ((1-((1-benzylpyrrolidin-2-yl)methyl)-3-ethyl-1H-imidazol-2(3H)-ylidene)-κ2C,N)dichloridopalladium(II), C17H23Cl2N3Pd
  43. Crystal structure of 9-allyl-4,5-dichloro-12-cyano-9,10-dihydro-9,10-ethanoanthracen-12-yl acetate, C22H17Cl2NO2
  44. Crystal structure of 4-bromo-2-(8-(3-ethoxy-2-hydroxyphenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)phenol, C18H19BrN2O5
  45. Crystal structure of 3-tert-butyl-3-hydroxy-1,3-dihydro-2H-pyrrolo[3,2-c]pyridin-2-one, C11H14N2O2
  46. Crystal structure of diaquabis(3-(3,5-dibromophenyl)-5-(pyridin-2-yl)-1,2,4-triazol-4-ido-κ2N,N′)nickel(II) mono hydrate, C26H20Br4N8NiO3
  47. Crystal structure of 5-(adamantan-1-yl)-3-[(2-trifluoromethylanilino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione, C20H22F3N3OS
  48. Crystal structure of 2-ethyl-1-tert-butyl-2-((4-fluorophenyl)(tert-butoxycarbonylamino)methyl)-3-oxo-pyrrolidine-1,2-dicarboxylate, C24H33FN2O7
  49. Crystal structure of bis(μ2-2-fluorobenzoato-κ2O:O:O′) bis(μ2-2-fluorobenzoato-κ2O:O′)dinitrato-κ2O,O′ bis(1,10-phenathroline-κ2N,N′)diterbium(III), C52H32F4N6O14Tb2
  50. Crystal structure of tetrabutylammonium 4-aminobenzenesulfonate 2/3 hydrate, C22H42N2O3S · 2/3 H2O
  51. Crystal structure of tetraethylammonium 4-aminobenzenesulfonate, C14H26N2O3S
  52. Crystal structure of bis(guanidinium) 3,3′-oxybis(6-carboxybenzoate), C18H20N6O9
  53. Crystal structure of N′-(4-methoxybenzylidene)-5-phenyl-1H-pyrazole-3-carbohydrazide, C18H16N4O2
  54. Crystal structure of N′-(4-nitrobenzylidene)-5-phenyl-1H-pyrazole-3-carbohydrazide, C17H13N5O3
  55. Crystal structure of 5-((4-bromophenyl)(2-hydroxy-6-oxocyclohex-1-en-1-yl)methyl)-6-hydroxy-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, C19H19BrN2O5
  56. Crystal structure of 3-(((cyclohexyl(phenyl)methylidene)amino)oxy)-2-hydroxy-N-(propan-2-yl)propan-1-aminium chloride, C19H31ClN2O2
  57. Crystal structure of 6-hydroxy-5-((2-hydroxy-6-oxocyclohex-1-en-1-yl)(phenyl)methyl)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, C19H20N2O5
  58. Crystal structure of 2-(4-(4-bromophenyl)thiazol-2-yl)isoindoline-1,3-dione, C17H9BrN2O2S
  59. Crystal structure of 2-(4-methylbenzoyl)pyrene, C24H16O
  60. Crystal structure of N-(5-bromo-4-(p-tolyl)thiazol-2-yl)-4-chlorobutanamide, C14H14BrClN2OS
  61. Crystal structure of 4,5-diphenylthiazol-2-amine, C15H12N2S
  62. Crystal structure of poly[bis(μ2-4-(3-(pyridin-3-yl)-1H-1,2,4-triazol-5-yl)benzoato-κ3N:O,O′)-lead(II)], C28H18O4N8Pb
  63. Crystal structure of (Z)-4-(4-oxopent-2-en-2-ylamino)benzenesulfonamide, C11H14N2O3S
  64. Crystal structure of poly[(μ2-2-methyl-1-(4-(2-methyl-2H-benzo[d] imidazol-1(7aH)-yl)butyl)-1H-benzo[d]imidazole-κ2N:N′)bis(μ3-5-tert-butylbenzene-1,3-dicarboxylato-κ4O:O,O′:O′′,O′′′)dicadmium(II)] tetrahydrate, C44H54Cd2N4O12
  65. Crystal structure of catena-poly-[aqua(μ2-4,4′-bipyridine-κ2N:N′)bis(3′,5,5′-tricarboxybiphenyl-2-carboxylato-κ2O,O′)cadmium(II)], C42H28N2O17Cd
  66. Crystal structure of (2RS,3RS)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol, C15H20ClN3O
  67. Crystal structure of N′-(4-(dimethylamino)benzylidene)-5-phenyl-1H-pyrazole-3-carbohydrazide, C19H19N5O
  68. Crystal structure of 3-(benzofuran-2-yl)-5-(4-fluorophenyl)-4,5-dihydro-1Hpyrazole-1-carbothioamide, C18H14FN3OS
  69. Crystal structure of ent-1β-acetoxy-7α,14α-di-hydroxy-7β,20-epoxykaur-16-en-15-one, C22H30O6
  70. Crystal structure of 1α,7β-dihydroxy-11β-acetoxy-ent-7β,20-epoxykaur-16-en-15-one, C22H30O6
  71. Crystal structure of 7β,14β,15β-trihydroxy-1α-acetoxy-7α,20-epoxy-ent-kaurane, C22H32O6
  72. Crystal structure of ent-1β,7α,11α-trihydroxy-7β,20-epoxykaur-16-en-15-one, C20H28O5
  73. Crystal structure of poly-[tetraaquabis(μ8-benzene-1,2,4,5-tetracarboxylato-1κ3O4:O6:O8:2κ4O2:O2:O5:O5:3κ4O1:O3:O5:O7)(di-μ3-hydroxido)-pentazinc(II)] decahydrate, C20H34O32Zn5
  74. Crystal structure of 1-(4-methylthiazol-2-yl)-3-propylthiourea, C8H13N3S2
  75. Crystal structure of 2-((dimethylamino)methylene)-5,5-Dimethylcyclohexane-1,3-dione, C11H17NO2
  76. Crystal structure of poly[1,4-bis(2-methylbenzimidazol)butane-κ2N:N′)bis(4,4′-oxybis(benzoato-κ4O,O′:O′′,O′′′)dicadmium] monohydrate, C48H38Cd2N4O10
  77. Crystal structure of 2-(3-(benzofuran-2-yl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-(4-chlorophenyl)thiazole, C26H17ClFN3OS
  78. Crystal structure of bis(μ3-isophthalato-κ3O:O′:O′′)(μ2-1,4-\ bis((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)benzene-κ2N:N′)dizinc(II), C22H19N2O4Zn
  79. Crystal structure of poly[bis(adipate-κ4O,O′:O′′, O′′′)(1,4-bis(2-methyl-1H-benzo[d]imidazol-1-yl)benzene-κ2N:N′)dizinc(II), C36H38N4O8Zn2
  80. Crystal structure of N-(2-(2-oxoindolin-4-yl)ethyl)-N-propylpropan-1-aminium tetraphenylborate, C40H45BN2O
  81. Crystal structure of 1-(2,3-dihydro-4-methyl-3-phenyl-2-thioxothiazol-5-yl)-1-ethanone, C12H11NOS2
  82. Crystal structure of 3-(adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-[(E)-(2,6-difluorobenzylidene)amino]-1H-1,2,4-triazole-5(4H)-thione, C31H36F2N6S
  83. Crystal structure of 6-(4-chlorophenyl)-3-(thiophen-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]-thiadiazole, C13H7ClN4S2
  84. Crystal structure of bis(ethanaminium) poly[bis(hexaselenido-κ2Se1,Se6)palladate(II)], C4H16N2PdSe12
  85. Crystal structure of 2-(3-(benzofuran-2-yl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)-4-phenylthiazole, C26H19N3OS
  86. Crystal structure of poly-[bis(μ3-5-hydroxyisophtalato-κ3O:O′:O′′)(μ2-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ2N:N′)dizinc(II)], C40H30N4O5Zn2
  87. Crystal structure of poly-[(μ-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ2N:N′)-bis(μ4-2,2′-(1,3-phenylene)diacetate-κ4O:O′:O′′:O′′′)dizinc(II)], C44H38N4O8Zn2
  88. Crystal structure of 5,17-bis-cyano-25,26,27,28-tetrapropyloxy-calix[4]arene, C42H46N2O4
  89. Crystal structure of poly-[μ-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ2N:N′)-bis(μ3-5-hydroxyisophthalate(2–)-κ3O,O′:O′′)dicadmium(II)] monohydrate, C64H54N8O11Cd2
  90. Crystal structure of poly-[μ-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ2N:N′)-bis(μ4-4,4′-sulfonyldibenzoato-κ4O:O′:O′′:O′′′)dicadmium(II)] monohydrate, C52H42N4O14Cd2
  91. Crystal structure of poly-[bis(μ4-adipato-κ4O:O′:O′′:O′′′)(μ2-1,4-bis((2-ethyl-1H-benzo[d]imidazol-1-yl)methyl)benzene-κ2N:N′)dizinc(II)], C38H42N4O8Zn2
  92. Crystal structure of (2-(2-chlorophenyl)-5-methyl-1,3-dioxan-5-yl)methanol, C12H15ClO3
  93. Crystal structure of 2-(4-Bromophenyl)-5-ethyl-1,3-dioxane-5-carboxylic acid, C13H15BrO4
  94. Crystal structure of (2-(4-bromophenyl)-5-ethyl-1,3-dioxan-5-yl)methanol, C13H17BrO3
  95. Crystal structure of 3-((1,3,5,7-tetraoxo-6-(pyridin-3-ylmethyl)-3,3a,4,4a,5,6,7,7a,8,8a-decahydro-4,8-ethenopyrrolo[3,4-f]isoindol-2(1H)-yl)methyl)pyridin-1-ium-κN-trichloridocobalt(II) hemihydrate, C24H22Cl3CoN4O4.5
  96. Crystal structure of 4-chloro-4′,6′-dichloro-2,2′-[propane-1,3-diyldioxybis(nitrilomethylidyne)]-diphenol, C17H14Cl3N2O4
  97. Crystal structure of 2-amino-4-(3-trifluoromethylphenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C17H13F3N2O2
  98. Crystal structure of bis(benzoato-κO)bis(4,4′-((1H-1,2,4-triazol-1-yl)methylene)dibenzonitrile-κN)zinc(II), C48H32N10O4Zn
  99. Crystal structure of 3-methyl-2H-chromen-2-one, C10H8O2
  100. Crystal structure of catena-poly-[aqua-(2-carboxy-5-(3-carboxy-5-carboxylatophenoxy)benzoato-κO)(μ2-4,4′-di(1H-imidazol-1-yl)-1,1′-biphenyl-κ2N:N′)cobalt(II)], C34H24N4O10Co
  101. Crystal structure of 4,4′-di(1H-imidazol-1-yl)-1,1′-biphenyl, C36H28N8
  102. Crystal structure of 1-(3-chloropropyl)piperidin-1-ium tetraphenylborate, C32H37BClN
  103. Crystal structure of dimethyl 5-(benzylamino)isophthalate, C17H17NO4
  104. Crystal structure of dimethyl 5-(dibenzylamino)isophthalate, C24H23NO4
  105. Crystal structure of N-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioamide, C21H29N3S
  106. Crystal structure of (2,2′(cyclohexane-1,2-diylbis(nitrilo(E)methylylidene))diphenolato-κ4O,O′,N,N′)dimethanolmanganese(III) bromide, C22H28BrMnN2O4
  107. Crystal structure of 3,5,7-tris(morpholinomethyl)tropolone·0.67 hydrate, C22H33N3O5·0.67H2O
  108. Crystal structure of biphenyl-2,3′,5,5′-tetracarboxylic acid – 4,4′-biphenyl-4,4′-diyldipyridine (3/2), C49H34N3O8
Heruntergeladen am 20.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2016-0015/html
Button zum nach oben scrollen